A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

OBJECTIVES: Treatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The aim of this trial was to assess the possibility of discontinuing treatment with adalimumab (ADA) while maintaining remission in patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Chatzidionysiou, Katerina, Turesson, Carl, Teleman, Annika, Knight, Ann, Lindqvist, Elisabet, Larsson, Per, Cöster, Lars, Forslind, Kristina, van Vollenhoven, Ronald, Heimbürger, Mikael
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716561/
https://ncbi.nlm.nih.gov/pubmed/26819752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados